Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Current Liabilities: 2020-2025

Historic Total Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $61.6 million.

  • Maravai Lifesciences Holdings' Total Current Liabilities fell 3.35% to $61.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.6 million, marking a year-over-year decrease of 3.35%. This contributed to the annual value of $57.0 million for FY2024, which is 34.87% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Total Current Liabilities of $61.6 million as of Q3 2025, which was down 11.64% from $69.7 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Total Current Liabilities high stood at $165.3 million for Q1 2021, and its period low was $57.0 million during Q4 2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Total Current Liabilities averaged around $73.5 million, with its median value being $68.6 million (2024).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Total Current Liabilities soared by 44.10% in 2023, and later slumped by 52.74% in 2024.
  • Maravai Lifesciences Holdings' Total Current Liabilities (Quarterly) stood at $93.8 million in 2021, then grew by 17.45% to $110.1 million in 2022, then dropped by 20.59% to $87.5 million in 2023, then crashed by 34.87% to $57.0 million in 2024, then dropped by 3.35% to $61.6 million in 2025.
  • Its Total Current Liabilities stands at $61.6 million for Q3 2025, versus $69.7 million for Q2 2025 and $63.2 million for Q1 2025.